Treatment of Epilepsy with Myoclonic Absences in Adults (Age 16 and Older)

Epilepsy with myoclonic absences (ICD-11 8A61.23) requires structured medication selection. This protocol is specific to adult patients aged 16 years and older.

Patient Population

Adults aged 16 years and older presenting with epilepsy with myoclonic absences.

Treatment Approach (Partial Overview)

First-line management involves initiating monotherapy with a level C antiepileptic agent.

Full agent selection, sequencing, and the complete structured regimen are available in the protocol below.

Instant Access to Structured Evidence-Based Regimens

References

Adults

Treatment should begin with monotherapy.

Level C: carbamazepine, lamotrigine, oxcarbazepine, phenobarbital, phenytoin, topiramate, valproic acid

View source ↗